Micron Products, Inc. Awarded Multi-Year Defense Industry Supply Order
FITCHBURG, MA--(Marketwire - January 22, 2008) - Micron Products, Inc. ("Micron"), a wholly
owned subsidiary of Arrhythmia Research Technology, Inc. (the "Company")
(AMEX: HRT), is pleased to announce it has been awarded a multi-year,
multi-million dollar supply order by KaZaK Composites, Inc. Under the
program, Micron will provide injection molding, precision machining,
fabrication and assembly services for KaZaK's proprietary product line of
lightweight, portable, quick release stanchions for a new class of combat
logistics force ships for the U.S. Navy.
James E. Rouse, the Company's President and CEO, commented, "KaZaK
Composites with its patented and proprietary advanced material technologies
is a tremendous partner for our manufacturing capabilities. Our services
to KaZaK will continue over the next several years and contribute to the
expansion of Micron and its divisions. We are proud of our partnership
with KaZaK in support of the U.S. Navy. With the increased breadth of
product offerings we continue our progress toward greater diversification
of our product lines and services, higher revenue and continued growth.
Micron's opportunity to provide these defense industry products to KaZaK
accentuates Micron's proven product life cycle management capabilities,
including value-added services from design support to production and
assembly. We are excited about the future as we continue to explore new
avenues for expansion of our business."
"We are pleased to partner with Micron Products on this project for the
U.S. Navy," said KaZaK Composites Executive Vice President John Schickling.
"It is essential to this project that we are able to meet the deadlines set
by the U.S. Navy and provide them with the highest quality product. In
evaluating Micron Products we were impressed with not only the high quality
of the product they were manufacturing, but also with their dependability
and their ability to adhere to a tight production schedule."
About Arrhythmia Research Technology, Inc.
The Company through its wholly owned subsidiary Micron Products, Inc.
manufactures silver plated and non-silver plated conductive resin sensors
and distributes metal snaps used in the manufacture of disposable ECG, EEG,
EMS and TENS electrodes. Micron's NEM division manufactures custom
injection molded products for medical, electronic, industrial and consumer
applications. Micron's MIT division provides end-to-end product life cycle
management through a comprehensive portfolio of value-added services such
as design, engineering, prototyping, manufacturing, machining, assembly and
packaging. Micron's Leominster Tool division provides high end mold design,
manufacturing and precision machining for various industries. The Company's
products also include proprietary signal-averaging electrocardiography
(SAECG) software used in the detection of potentially lethal heart
arrhythmias.
For more information please visit our websites:
About KaZaK Composites
Headquartered in Woburn, MA, KaZaK Composites, Inc. integrates engineering
design and low-cost manufacturing to produce high performance composites
for the aerospace, military and commercial markets. With specialization in
large and unusual pultrusion processing, KaZaK Composites, Inc. provides
product value in the area of material sciences that has enabled engineers
to develop new and creative ways to build structures. KaZaK Composites,
Inc. also has a facility in Hudson, NH. For more information, please visit
www.kazakcomposites.com.
Note Regarding Forward-Looking Statements
Forward-looking statements made herein are based on current expectations of
the Company that involve a number of risks and uncertainties and should not
be considered as guarantees of future performance. The factors that could
cause actual results to differ materially include: interruptions or
cancellation of existing contracts, impact of competitive products and
pricing, product demand and market acceptance, risks, the presence of
competitors with greater financial resources than the Company, product
development and commercialization risks, and changing economic conditions
in developing countries. More information about factors that potentially
could affect the Company's financial results is included in the Company's
filings with the Securities and Exchange Commission, including its Annual
Report on Form 10-KSB for the year ended December 31, 2006 available on
the Company's website or at www.sec.gov.